Spinal and bulbar muscular atrophy is a neuromuscular disorder caused by a toxic polyglutamine (polyQ) expansion in the androgen receptor (AR). An isoform of the AR (AR-A) results from translation driven by an AUG(-II) downstream to the canonical AUG-I of AR. AR-A isoform lacks part of the N-terminal domain, including the polyQ tract. Redirecting the translation start site to the AUG-II might represent a strategy to avoid the expression of the toxic ARpolyQ, while preserving partial AR function of the shorter AR-A isoform. Strategies to switch the translation to AR-A isoform include the use of antisense oligonucleotides (ASO) to induce a steric blockage at the AUG-I encoding AR-B. To screen the ASO ability to switch AR-B to AR-A translation, we generated a reporter SH-SY5Y cell line (pScreen) expressing GFP or HiBit in frame with AUG-I or AUG-II, respectively. Ten ASOs were tested on pScreen cells, followed by HiBiT assay and GFP detection through western blot. The HiBiT assay showed that one ASO (#6) increased HiBiT-related luminescence normalised to cell viability, suggesting the induction of translation starting from the AUG-II. Instead, when we evaluated the reporter for AUG-I translation, ASO #6 also decreased GFP protein levels. In summary, there is evidence that the expression of AR isoforms can be modulated; however, the mechanisms underlying this regulation require further validation.
Strategies to promote the expression of the androgen receptor AR-A isoform lacking the polyglutamine tract in spinal and bulbar muscular atrophy / B. Tedesco, M. Chierichetti, P. Pramaggiore, V. Ferrari, L. Cornaggia, M. Cozzi, A.A.M. Mohamed, V. Marchesi, M. Piccolella, V. Crippa, P. Rusmini, M. Galbiati, C. Rinaldi, R.M. Cristofani, A. Poletti. ((Intervento presentato al convegno RNA-based innovative therapies for neurological disorders tenutosi a Napoli nel 2025.
Strategies to promote the expression of the androgen receptor AR-A isoform lacking the polyglutamine tract in spinal and bulbar muscular atrophy
B. TedescoPrimo
;M. Chierichetti;P. Pramaggiore;V. Ferrari;L. Cornaggia;M. Cozzi;A.A.M. Mohamed;V. Marchesi;M. Piccolella;V. Crippa;P. Rusmini;M. Galbiati;R.M. Cristofani;A. PolettiUltimo
2025
Abstract
Spinal and bulbar muscular atrophy is a neuromuscular disorder caused by a toxic polyglutamine (polyQ) expansion in the androgen receptor (AR). An isoform of the AR (AR-A) results from translation driven by an AUG(-II) downstream to the canonical AUG-I of AR. AR-A isoform lacks part of the N-terminal domain, including the polyQ tract. Redirecting the translation start site to the AUG-II might represent a strategy to avoid the expression of the toxic ARpolyQ, while preserving partial AR function of the shorter AR-A isoform. Strategies to switch the translation to AR-A isoform include the use of antisense oligonucleotides (ASO) to induce a steric blockage at the AUG-I encoding AR-B. To screen the ASO ability to switch AR-B to AR-A translation, we generated a reporter SH-SY5Y cell line (pScreen) expressing GFP or HiBit in frame with AUG-I or AUG-II, respectively. Ten ASOs were tested on pScreen cells, followed by HiBiT assay and GFP detection through western blot. The HiBiT assay showed that one ASO (#6) increased HiBiT-related luminescence normalised to cell viability, suggesting the induction of translation starting from the AUG-II. Instead, when we evaluated the reporter for AUG-I translation, ASO #6 also decreased GFP protein levels. In summary, there is evidence that the expression of AR isoforms can be modulated; however, the mechanisms underlying this regulation require further validation.| File | Dimensione | Formato | |
|---|---|---|---|
|
Abstract TEDESCO_PNRR Oct2025.pdf
accesso aperto
Descrizione: Abstract
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
379.16 kB
Formato
Adobe PDF
|
379.16 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




